Skip to main content
Skip to section navigation
Skip to footer
Product Indications
Back to Viveve.com
Product Indications
VIVEVE
®️
SYSTEM
In the United States the Viveve System is cleared by the FDA for general surgery procedures for electrocoagulation and hemostasis.
The Viveve System has received regulatory approvals and clearances in many countries throughout the world and is available through physician import license in Japan and China. International approvals and clearances include vaginal laxity and/or improvement of sexual function indications. In Argentina improvement of urinary incontinence in women is also an approved indication.
Investor Relations
Investors
Overview
News & Events
Overview
Press Releases
Publications
IR Calendar
Analyst Coverage
Email Alerts
Company Info
Overview
Leadership Team
Clinical Advisory Board
Presentations
Contacts
FAQ
Financial Info
Overview
Financial Results
Income Statement
Balance Sheet
Cash Flow
Stock Data
Quote
Charts
Historical Data
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Overview
Board of Directors
Governance Documents
Board Diversity Matrix
Back to Viveve.com
Financial Information
Financial Info
Financial Info
Overview
Financial Results
Income Statement
Balance Sheet
Cash Flow
Latest Financial Results
Q3 2022
Quarter Ended Sep 30, 2022
Earnings Release
PDF
HTML
Earnings Webcast
Audio
10-Q
Filing
PDF
HTML
XBRL
ZIP
XLS
Latest 10-K
View HTML
View PDF
Financials
View the latest financials
Income Statement
Balance Sheet
Cash Flow
Email Alerts
Contacts
RSS News Feed